The Fat-Based Injectable Fillers market size is expected to reach $1.18 billion by 2030 at a CAGR of 10.9%, driven by growing demand for minimally invasive aesthetic procedures.
Read More
The Environmental Allergy Monitoring market size is expected to reach $1.36 billion by 2030 at a CAGR of 13.0%, driven by rising prevalence of allergic diseases.
Read More
The Drug Of Abuse Testing market size is expected to reach $9.97 billion by 2030 at a CAGR of 6.9%, driven by rising prevalence of substance abuse and addiction.
Read MoreComputed Tomography (CT)-Guided Biopsy Market Outlook Highlights The Next Major Growth Opportunities
The Computed Tomography (CT)-Guided Biopsy market size is expected to reach $1.06 billion by 2030 at a CAGR of 6.6%, driven by rising incidence of cancer.
Read MoreThe Biomarker-Based Immunoassays market size is expected to reach $11.55 billion in 2030 at a CAGR of 11.9%, driven by increasing incidence of oncology cases.
Read MoreThe At-Home Sexually Transmitted Infection (STI) Testing market size is expected to reach $3.55 billion in 2030 at a CAGR of 13.0%, driven by growing awareness of sexual health.
Read MoreThe Asthma-Chronic Obstructive Pulmonary Disease (COPD) Overlap Treatment market size is expected to reach $14.27 billion in 2030 at a CAGR of 8.7%, driven by growing demand for precision medicine.
Read MoreThe AI-Enabled Wound Analysis market size is expected to reach $2.28 billion in 2030 at a CAGR of 14.3%, driven by growing adoption of personalized medicine.
Read More
The wastewater biothreat genomics market is projected to reach $3.01B by 2030, driven by biosecurity investments, early outbreak detection, AI genomic analytics, and sewage-based pathogen surveillance.
Read More
The virtual ward market is projected to reach $5B by 2030, driven by home care adoption, remote patient monitoring, connected medical devices, and hospital-at-home models.
Read More